A REPORT COMPARING THE USE OF TROPISETRON (NAVOBAN), A 5-HT3 ANTAGONIST, WITH A STANDARD ANTIEMETIC REGIMEN OF DEXAMETHASONE AND METOCLOPRAMIDE IN CISPLATIN-TREATED PATIENTS UNDER CONDITIONS OF SEVERE EMESIS

Authors
MADEJ G KRZAKOWSKI M PAWINSKI A LASOTA W ROGOWSKI W SKONECZNA I
Citation
G. Madej et al., A REPORT COMPARING THE USE OF TROPISETRON (NAVOBAN), A 5-HT3 ANTAGONIST, WITH A STANDARD ANTIEMETIC REGIMEN OF DEXAMETHASONE AND METOCLOPRAMIDE IN CISPLATIN-TREATED PATIENTS UNDER CONDITIONS OF SEVERE EMESIS, Seminars in oncology, 21(5), 1994, pp. 3-6
Citations number
12
Categorie Soggetti
Oncology
Journal title
Seminars in oncology → ACNP
ISSN journal
00937754
Volume
21
Issue
5
Year of publication
1994
Supplement
9
Pages
3 - 6
Database
ISI
SICI code
0093-7754(1994)21:5<3:ARCTUO>2.0.ZU;2-E